Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Modeling Parkinson's disease using induced pluripotent stem cells.

Current neurology and neuroscience reports - 1 Jun 2012

Byers Blake, Lee Hsiao-lu, Reijo Pera Renee

Abstract excerpt

Our understanding of the underlying molecular mechanism of Parkinson's disease (PD) is hampered by a lack of access to affected human dopaminergic (DA) neurons on which to base experimental research. Fortunately, the recent development of a PD disease model using induced pluripotent stem cells (iPSCs) provides access to cell types that were previously unobtainable in sufficient quantity or quality, and presents...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to alpha-Synuclein
Share to Cell Line
Share to Dopaminergic Neurons

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Leucine-Rich Repeat Serine-Threonine Protein Kinase-2

Share to Models, Biological

Share to Parkinson Disease

Share to Pluripotent Stem Cells

Share to Protein Serine-Threonine Kinases

Source

Open in PubMed Open full text

Identifiers

PMID: 22538490
DOI: 10.1007/s11910-012-0270-y
PMCID: PMC3342500

Genes

SNCA

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Modeling Parkinson's disease using induced pluripotent stem cells.PMID 22538490Read ↗

LRRK2 mutant iPSC-derived DA neurons demonstrate increased susceptibility to oxidative stress.Semantic proximity Read ↗

Modeling Parkinson’s Disease Using Induced Pluripotent Stem CellsSemantic proximity Read ↗

Modeling Parkinson's disease with induced pluripotent stem cells harboring α-synuclein mutations.Semantic proximity Read ↗

SNCA triplication Parkinson's patient's iPSC-derived DA neurons accumulate α-synuclein and are susceptible to oxidative stress.Semantic proximity Read ↗

Modeling Parkinson’s Disease Using Patient-specific Induced Pluripotent Stem CellsSemantic proximity Read ↗

Induced pluripotent stem cell (iPSC)-derived dopaminergic models of Parkinson's diseaseSemantic proximity Read ↗

Parkinson's disease induced pluripotent stem cells with triplication of the α-synuclein locusSemantic proximity Read ↗

Using induced pluripotent stem cells for modeling Parkinson’s diseaseSemantic proximity Read ↗

Mitochondrial dysfunction and oxidative stress in induced pluripotent stem cell models of Parkinson's diseaseSemantic proximity Read ↗

Parkinson's disease in a dish - Using stem cells as a molecular tool.Semantic proximity Read ↗

iPS models of Parkin and PINK1.Semantic proximity Read ↗

Induced pluripotent stem cells and Parkinson's disease: modelling and treatmentSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.